Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies

NCT00040417 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped unable to accrue patients

Conditions

Sickle Cell Anemia
Hemoglobinopathy
Thalassemia

Interventions

DRUG: FLUDARABINE
DRUG: CAMPATH-IH
PROCEDURE: Total Body Irradiation
DRUG: FK506
DRUG: G-SCF (Granulocyte-colony stimulating factor)

Sponsor

Baylor College of Medicine

Collaborators

[object Object]